Does RISANKIZUMAB-RZAA Cause Dysphonia? 101 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Dysphonia have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
101
Reports of Dysphonia with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
1
Deaths
10
Hospitalizations
How Dangerous Is Dysphonia From RISANKIZUMAB-RZAA?
Of the 101 reports, 1 (1.0%) resulted in death, 10 (9.9%) required hospitalization, and 2 (2.0%) were considered life-threatening.
Is Dysphonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 101 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dysphonia?
FLUTICASONE\SALMETEROL (1,729)
CABOZANTINIB S-MALATE (1,229)
ADALIMUMAB (1,216)
BUDESONIDE\FORMOTEROL (1,204)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (1,143)
ALBUTEROL (1,114)
LENVATINIB (1,021)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (943)
LENALIDOMIDE (931)
AMIKACIN (914)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dysphonia Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA